|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400088304 |
|
最近更新日期: Date of Last Refreshed on: |
2024-08-15 14:20:48 |
|
注册时间: Date of Registration: |
2024-08-15 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
调脏疏经推拿技术结合针刺组穴治疗中风后痉挛性瘫痪的临床研究 |
|
Public title: |
Randomized controlled study on the treatment of post-stroke spasticity by massage based on Tiaozang Shujing theory and acupuncture |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
调脏疏经推拿技术结合针刺组穴治疗中风后痉挛性瘫痪的临床研究 |
|
Scientific title: |
Randomized controlled study on the treatment of post-stroke spasticity by massage based on Tiaozang Shujing theory and acupuncture |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王肖煜 |
研究负责人: |
蒋涛 |
|
Applicant: |
Wang Xiaoyu |
Study leader: |
Jiang Tao |
|
申请注册联系人电话: Applicant telephone: |
+86 188 1256 5579 |
研究负责人电话:
Study leader's |
+86 139 5608 2716 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yu1261070153@163.com |
研究负责人电子邮件: Study leader's E-mail: |
13956082716@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
安徽省合肥市寿春路300号安徽中医药大学第二附属医院 |
研究负责人通讯地址: |
安徽省合肥市寿春路300号安徽中医药大学第二附属医院 |
|
Applicant address: |
NO300, Shou Chun Road, The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei City, Anhui province. China. |
Study leader's address: |
NO300, Shou Chun Road, The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei City, Anhui province. China. |
|
申请注册联系人邮政编码: Applicant postcode: |
230061 |
研究负责人邮政编码: Study leader's postcode: |
230061 |
|
申请人所在单位: |
安徽中医药大学第二附属医院 |
||
|
Applicant's institution: |
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
安徽中医药大学第二附属医院 |
||
|
Affiliation of the Leader: |
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024-zj-02 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
安徽中医药大学第二附属医院(安徽省针灸医院)伦理委员会 |
||
|
Name of the ethic committee: |
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine(Anhui Acupuncture & Moxibustion Hospital) Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-02-06 00:00:00 | ||
|
伦理委员会联系人: |
束樱子 |
||
|
Contact Name of the ethic committee: |
Shu Yingzi |
||
|
伦理委员会联系地址: |
安徽省合肥市寿春路300号安徽中医药大学第二附属医院 |
||
|
Contact Address of the ethic committee: |
NO300, Shou Chun Road, The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei City, Anhui province. China. |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 551 6266 8814 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
安徽中医药大学第二附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
安徽省合肥市寿春路300号安徽中医药大学第二附属医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
NO300, Shou Chun Road, The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei City, Anhui province. China. |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
安徽省卫生健康科研项目(AHWJ2023A10020) |
||||||||||||||||||||||
|
Source(s) of funding: |
Health Research Project of Anhui(AHWJ2023A10020) |
||||||||||||||||||||||
|
研究疾病: |
中风后痉挛性瘫痪 |
||||||||||||||||||||||
|
Target disease: |
Post-stroke spasticity |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探讨调脏疏经推拿法结合针刺治疗中风后痉挛性瘫痪的临床疗效和相关作用机制,以期为临床治疗中风后痉挛性瘫痪提供新的诊疗方案,并为调脏疏经推拿结合针刺治疗中风后痉挛性瘫痪提供理论依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to explore the clinical efficacy and related mechanisms of the the treatment of post-stroke spasticity by massage based on Tiaozang Shujing theory and acupuncture. It is hoped that this study can provide a new diagnosis and treatment plan for this disease and explain its theoretical reasons. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
① 符合脑卒中诊断标准,经头颅CT或者MRI等影像学资料佐证的患者; ② 年龄在 18~75 岁之间,性别不限; ③ 患者意识清楚,生命体征平卧,认知能力正常,病程在6个月以内; ④ 患侧肢体 Brunnstrom 分期在 II-IV 期,改良的 Ashworth 评定在 1~3 级,伴有瘫痪患侧肢体肌张力增高症状; ⑤ 两周内未服用过中西镇静药物及肌肉松弛剂者; ⑥ 自愿参加本项临床试验,服从诊疗方案,并签署知情同意书者。 △注:需同时满足上述6项才能纳入。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients who meet the diagnostic criteria for stroke and supported by imaging data such as cranial CT or MRI; 2. Age between 18 and 75 years old, gender not limited; 3. The patient is conscious, with vital signs lying flat and normal cognitive ability. The course of the disease is within 6 months; 4. The Brunstrom staging of the affected limb is in stages II-IV, and the modified Ashworth assessment is in grades 1-3, accompanied by symptoms of increased muscle tone in the paralyzed affected limb; 5. Those who have not taken any Chinese or Western sedatives or muscle relaxants within two weeks; 6. Those who voluntarily participate in this clinical trial, comply with the diagnosis and treatment plan, and sign the informed consent form. △ Note: To be included, the above six items must be met simultaneously. |
||||||||||||||||||||||
|
排除标准: |
① 中风次数≥3次者; ② 经检查证实是由其他疾病引起的肢体痉挛; ③ 已接受其它治疗者; ④ 合并有严重基础疾病及精神病患者; ⑤ 蛛网膜下腔出血患者,有其他出血性疾病或凝血功能障碍患者; ⑥ 妊娠或哺乳期妇女。 △注:凡出现以上任一项者,即从本课题排除。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Those who have had at least 3 strokes; 2. Confirmed through examination that limb spasms are caused by other diseases; 3. Those who have received other treatments; 4. Merge patients with severe underlying diseases and mental illnesses; 5. Patients with subarachnoid hemorrhage, other bleeding disorders or coagulation dysfunction; 6. Pregnant or lactating women. △ Note: Any of the above conditions shall be excluded from this study. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-06-15 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-08-15 00:00:00 至 To 2026-11-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由统计人员用计算机软件随机分组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Randomly grouped by statisticians using computer software |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
- |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
- |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究将使用病例记录表来记录研究过程中产生的数据。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This study will use a case record form to document the data generated during the research process. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |